Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Diabetes Sci Technol. 2012 Jul 1;6(4):797-801.

Undeniable need for ultrafast-acting insulin: the pediatric perspective.

Author information

  • 1Division of Pediatric Endocrinology and Diabetes, Yale University School of Medicine, New Haven, Connecticut 06520, USA. Eda.Cengiz@yale.edu

Abstract

Insulin therapy in youth with type 1 diabetes mellitus (T1DM) poses a special challenge because childhood is an unsteady state with increasing weight, height, and caloric needs, leading to varying insulin requirements. The current rapid-acting insulin analogs are not as fast and short-acting as needed to meet these challenges. This review describes the unique characteristics of insulin action in youth with T1DM based on previously published euglycemic clamp studies. It also explains the rationale behind the need for ultrafast-acting insulins to advance open- and closed-loop insulin therapy for the pediatric population with diabetes. Lastly, it briefly summarizes ongoing and future projects to accelerate insulin action in youth with T1DM.

© 2012 Diabetes Technology Society.

PMID:
22920804
[PubMed - indexed for MEDLINE]
PMCID:
PMC3440149
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk